156 related articles for article (PubMed ID: 3374770)
1. Pharmacological characterization of serotonin 5-HT3 receptor-mediated electrical response in cultured mouse neuroblastoma cells.
Neijt HC; te Duits IJ; Vijverberg HP
Neuropharmacology; 1988 Mar; 27(3):301-7. PubMed ID: 3374770
[TBL] [Abstract][Full Text] [Related]
2. Competitive and non-competitive effects of 5-hydroxyindole on 5-HT3 receptors in N1E-115 neuroblastoma cells.
Kooyman AR; van Hooft JA; Vanderheijden PM; Vijverberg HP
Br J Pharmacol; 1994 Jun; 112(2):541-6. PubMed ID: 8075873
[TBL] [Abstract][Full Text] [Related]
3. The agonist properties of m-chlorophenylbiguanide and 2-methyl-5-hydroxytryptamine on 5-HT3 receptors in N1E-115 neuroblastoma cells.
Sepúlveda MI; Lummis SC; Martin IL
Br J Pharmacol; 1991 Oct; 104(2):536-40. PubMed ID: 1797317
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological consequences of ligand binding to the desensitized 5-HT3 receptor in mammalian NG108-15 cells.
Bartrup JT; Newberry NR
J Physiol; 1996 Feb; 490 ( Pt 3)(Pt 3):679-90. PubMed ID: 8683467
[TBL] [Abstract][Full Text] [Related]
5. Actions of general anaesthetics on 5-HT3 receptors in N1E-115 neuroblastoma cells.
Jenkins A; Franks NP; Lieb WR
Br J Pharmacol; 1996 Apr; 117(7):1507-15. PubMed ID: 8730747
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of 5-HT3 receptor cation channels by ifenprodil in excised patches of N1E-115 cells.
Barann M; Bönisch H; Urban BW; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):145-52. PubMed ID: 9749998
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of the membrane current mediated by serotonin 5-HT3 receptors in cultured mouse neuroblastoma cells.
Neijt HC; Plomp JJ; Vijverberg HP
J Physiol; 1989 Apr; 411():257-69. PubMed ID: 2482354
[TBL] [Abstract][Full Text] [Related]
8. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
Hoyer D; Neijt HC
Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
[TBL] [Abstract][Full Text] [Related]
9. Characterization of 5-HT3 and 'atypical' 5-HT receptors mediating guinea-pig ileal contractions in vitro.
Eglen RM; Swank SR; Walsh LK; Whiting RL
Br J Pharmacol; 1990 Nov; 101(3):513-20. PubMed ID: 2076474
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
Brüss M; Molderings GJ; Bönisch H; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
[TBL] [Abstract][Full Text] [Related]
11. Expression of 5-HT3 receptors in PC12 cells treated with NGF and 8-Br-cAMP.
Furukawa K; Akaike N; Onodera H; Kogure K
J Neurophysiol; 1992 Apr; 67(4):812-9. PubMed ID: 1588384
[TBL] [Abstract][Full Text] [Related]
12. 5-HT3 receptors in outside-out patches of N1E-115 neuroblastoma cells: basic properties and effects of pentobarbital.
Barann M; Göthert M; Bönisch H; Dybek A; Urban BW
Neuropharmacology; 1997; 36(4-5):655-64. PubMed ID: 9225291
[TBL] [Abstract][Full Text] [Related]
13. Modulation of afferent-evoked neurotransmission by 5-HT3 receptors in young rat dorsal horn neurones in vitro: a putative mechanism of 5-HT3 induced anti-nociception.
Khasabov SG; Lopez-Garcia JA; Asghar AU; King AE
Br J Pharmacol; 1999 Jun; 127(4):843-52. PubMed ID: 10433490
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological analysis of 5-hydroxytryptamine effects on electrically stimulated human isolated urinary bladder.
Corsi M; Pietra C; Toson G; Trist D; Tuccitto G; Artibani W
Br J Pharmacol; 1991 Nov; 104(3):719-25. PubMed ID: 1797331
[TBL] [Abstract][Full Text] [Related]
15. Characterization of 5-HT3 receptors of N1E-115 neuroblastoma cells by use of the influx of the organic cation [14C]-guanidinium.
Bönisch H; Barann M; Graupner J; Göthert M
Br J Pharmacol; 1993 Feb; 108(2):436-42. PubMed ID: 7680594
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 5-HT3 receptor-mediated ion current by divalent metal cations in NCB-20 neuroblastoma cells.
Lovinger DM
J Neurophysiol; 1991 Oct; 66(4):1329-37. PubMed ID: 1722246
[TBL] [Abstract][Full Text] [Related]
17. Agonist and antagonist effects of apomorphine enantiomers on 5-HT3 receptors.
van Hooft JA; Vijverberg HP
Neuropharmacology; 1998; 37(2):259-64. PubMed ID: 9680251
[TBL] [Abstract][Full Text] [Related]
18. The dopamine response in mouse neuroblastoma cells is mediated by serotonin 5HT3 receptors.
Neijt HC; Vijverberg HP; Van den Bercken J
Eur J Pharmacol; 1986 Aug; 127(3):271-4. PubMed ID: 3758183
[TBL] [Abstract][Full Text] [Related]
19. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
20. RS-056812-198: partial agonist on native and antagonist on cloned 5-HT3 receptors.
Van Hooft JA; Vijverberg HP
Eur J Pharmacol; 1997 Mar; 322(2-3):229-33. PubMed ID: 9098692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
